IRS1 and acute lymphoblastic leukemia: As expected, IGF-1 significantly increased the levels of IRS1 and phosphorylated AKT (Ser473) in primary pre-B ALL cells and reversed increases in IRS1 and phosphorylated AKT in primary pre-B ALL cells after treatment with GZD824 (Figure 6D).